Literature DB >> 28808827

Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma.

Fu Zhao1,2, Chunde Li3, Qiangyi Zhou3, Peiran Qu4, Bo Wang3, Xin Wang4,3, Shun Zhang3, Xingchao Wang3, Chi Zhao5, Jing Zhang5, Lin Luo6, Lin Ai4, Lei Xu7, Pinan Liu8,9.   

Abstract

Medulloblastoma (MB) is recognized as comprising four molecular subgroups with distinct transcriptional profiles, clinical features, and outcomes. Previous studies demonstrate that pediatric MBs present with subgroup-specific MRI manifestations. We hypothesized that combination of anatomical localization and conventional features based on MR imaging can predict these subgroups in adult MBs. MR Imaging manifestations of 125 adult patients with MB were analyzed retrospectively based on pre-operative MRI scans. MB molecular subgroups were evaluated by the expression profiling array and immunohistochemistry. A pediatric MB cohort of 60 patients were analyzed for comparison with data of adult patients. Multiple logistic regression analysis revealed that tumor location (P < 0.0001) and pattern of enhancement (P = 0.0048) were significantly correlated with molecular subgroups in adult MBs. Ninety-two percent of adult MBs were correctly predicted by using logistic regression model based on the anatomical localization patterns and pattern of enhancement. Exclusively intra-cerebellar growth, localization in the rostral cerebellum, and no brainstem contact were specific to adult SHH-MBs. Group 4-MBs in adult were characterized by minimal/no enhancement compared with other two subgroups. Infant SHH-MBs represented significant different localization patterns compared with SHH tumors in children and adults. We identified that molecular subgroups of adult MBs could be well predicted by tumor localization patterns and enhancement pattern. Our study also provided important evidence that MB subgroups in adult possibly derived from different cellular origins.

Entities:  

Keywords:  Adult; Localization; MRI; Medullobalstoma; Molecular subgroup

Mesh:

Year:  2017        PMID: 28808827     DOI: 10.1007/s11060-017-2581-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Adult medulloblastoma comprises three major molecular variants.

Authors:  Marc Remke; Thomas Hielscher; Paul A Northcott; Hendrik Witt; Marina Ryzhova; Andrea Wittmann; Axel Benner; Andreas von Deimling; Wolfram Scheurlen; Arie Perry; Sidney Croul; Andreas E Kulozik; Peter Lichter; Michael D Taylor; Stefan M Pfister; Andrey Korshunov
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  MR Imaging Characteristics of Wingless-Type-Subgroup Pediatric Medulloblastoma.

Authors:  Z Patay; L A DeSain; S N Hwang; A Coan; Y Li; D W Ellison
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

3.  Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.

Authors:  Andrey Korshunov; Marc Remke; Wiebke Werft; Axel Benner; Marina Ryzhova; Hendrik Witt; Dominik Sturm; Andrea Wittmann; Anna Schöttler; Jörg Felsberg; Guido Reifenberger; Stefan Rutkowski; Wolfram Scheurlen; Andreas E Kulozik; Andreas von Deimling; Peter Lichter; Stefan M Pfister
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

4.  Isolation of neural stem cells from the postnatal cerebellum.

Authors:  Audra Lee; Jessica D Kessler; Tracy-Ann Read; Constanze Kaiser; Denis Corbeil; Wieland B Huttner; Jane E Johnson; Robert J Wechsler-Reya
Journal:  Nat Neurosci       Date:  2005-05-22       Impact factor: 24.884

5.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

6.  Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct.

Authors:  Paul A Northcott; Thomas Hielscher; Adrian Dubuc; Stephen Mack; David Shih; Marc Remke; Hani Al-Halabi; Steffen Albrecht; Nada Jabado; Charles G Eberhart; Wieslawa Grajkowska; William A Weiss; Steven C Clifford; Eric Bouffet; James T Rutka; Andrey Korshunov; Stefan Pfister; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2011-06-17       Impact factor: 17.088

7.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

8.  Molecular subgroups of adult medulloblastoma: a long-term single-institution study.

Authors:  Fu Zhao; Hiroko Ohgaki; Lei Xu; Felice Giangaspero; Chunde Li; Peng Li; Zhijun Yang; Bo Wang; Xingchao Wang; Zhenmin Wang; Lin Ai; Jing Zhang; Lin Luo; Pinan Liu
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

9.  CT and MR imaging findings in adults with cerebellar medulloblastoma: comparison with findings in children.

Authors:  P M Bourgouin; D Tampieri; S Z Grahovac; C Léger; R Del Carpio; D Melançon
Journal:  AJR Am J Roentgenol       Date:  1992-09       Impact factor: 3.959

10.  Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.

Authors:  Paul A Northcott; David J H Shih; Marc Remke; Yoon-Jae Cho; Marcel Kool; Cynthia Hawkins; Charles G Eberhart; Adrian Dubuc; Toumy Guettouche; Yoslayma Cardentey; Eric Bouffet; Scott L Pomeroy; Marco Marra; David Malkin; James T Rutka; Andrey Korshunov; Stefan Pfister; Michael D Taylor
Journal:  Acta Neuropathol       Date:  2011-11-06       Impact factor: 17.088

View more
  8 in total

1.  Lateral cerebellum is preferentially sensitive to high sonic hedgehog signaling and medulloblastoma formation.

Authors:  I-Li Tan; Alexandre Wojcinski; Harikrishna Rallapalli; Zhimin Lao; Reeti M Sanghrajka; Daniel Stephen; Eugenia Volkova; Andrey Korshunov; Marc Remke; Michael D Taylor; Daniel H Turnbull; Alexandra L Joyner
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

2.  Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.

Authors:  Fu Zhao; Jing Zhang; Peng Li; Qiangyi Zhou; Shun Zhang; Chi Zhao; Bo Wang; Zhijun Yang; Chunde Li; Pinan Liu
Journal:  J Neurooncol       Date:  2018-04-23       Impact factor: 4.130

3.  MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.

Authors:  M Iv; M Zhou; K Shpanskaya; S Perreault; Z Wang; E Tranvinh; B Lanzman; S Vajapeyam; N A Vitanza; P G Fisher; Y J Cho; S Laughlin; V Ramaswamy; M D Taylor; S H Cheshier; G A Grant; T Young Poussaint; O Gevaert; K W Yeom
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-06       Impact factor: 3.825

4.  Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study.

Authors:  Xi Chen; Zhen Fan; Kay Ka-Wai Li; Guoqing Wu; Zhong Yang; Xin Gao; Yingchao Liu; Haibo Wu; Hong Chen; Qisheng Tang; Liang Chen; Yuanyuan Wang; Ying Mao; Ho-Keung Ng; Zhifeng Shi; Jinhua Yu; Liangfu Zhou
Journal:  Neurooncol Adv       Date:  2020-06-22

5.  The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.

Authors:  Tao Wu; Pei-Ran Qu; Shun Zhang; Shi-Wei Li; Jing Zhang; Bo Wang; Pinan Liu; Chun-de Li; Fu Zhao
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

Review 6.  MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.

Authors:  Giovanna Stefania Colafati; Ioan Paul Voicu; Chiara Carducci; Evelina Miele; Andrea Carai; Simona Di Loreto; Antonio Marrazzo; Antonella Cacchione; Valerio Cecinati; Assunta Tornesello; Angela Mastronuzzi
Journal:  Ther Adv Neurol Disord       Date:  2018-06-18       Impact factor: 6.570

7.  Medulloblastoma in a 6 Year Old Mixed Breed Dog: Surgical Debulking and Chemotherapy.

Authors:  Rachel Lampe; Miranda D Vieson; Devon Hague; Dana Connell; Kari Foss; Kim A Selting
Journal:  Front Vet Sci       Date:  2019-11-14

8.  Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study.

Authors:  Qilin Qin; Dezhi Huang; Yugang Jiang
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.